PPARD and metabolic syndrome: If this were the case, we expected that a compoundwhich can effectively activate both PPARα and PPARδ might have additive and/orsynergistic positive effect(s) in the treatment of metabolic syndrome, bymodulating both hepatic fatty acid oxidation through PPARα, and fatty acid oxidationand energy uncoupling in muscle and adipose tissue through PPARδ.